Snap Q2 2025: Ad Glitch Impacts Revenue, User Growth Strong
Snap's Q2 revenue missed estimates due to an ad platform glitch & policy changes. User growth and Snapchat+ remain strong points.
Feed↓
/ What's going on?
Filter:
AMD AI: Growth Trajectory Meets China Hurdles
AMD's Q3 revenue outlook is strong, but China AI chip sales face uncertainty as licenses are under review.
Novo Nordisk Navigates US Market Headwinds & Leadership Shift
Novo Nordisk faces slowing growth, fierce competition from Eli Lilly and copycats in the US, prompting a CEO change and strategic refocus.
Yum! Brands Q2 Challenges & Strategic Response
Yum! Brands missed Q2 targets due to rising costs and soft demand. Taco Bell slowed, KFC/Pizza Hut saw declines. Value deals and AI are key strategies.
SERB Acquires Y-mAbs: Rare Oncology Expansion
SERB Pharmaceuticals acquires Y-mAbs for $412M, gaining DANYELZA, an FDA-approved treatment for high-risk neuroblastoma, enhancing rare oncology portfolio.
Pfizer's Profit Outlook Rises Amidst Strong Q2 Performance
Pfizer boosts its 2025 profit forecast due to ongoing cost reductions and strong second-quarter sales driven by top-performing drugs.